Uncategorized

We gathered speakers and attendees from Digital Pharma East to share their experience at this face to face event as well as share the highlights

The stakes have never been higher for biotech, pharma, and medtech sales organizations. We explore ways that medical affairs, sales, and all customer-facing professionals can exceed the expectations of their customers and companies.

Delivering and Delighting HCP’s Everyone in the biopharmaceutical and MedTech space knows that customer-facing teammates need to win the attention of the health care professionals in order to convey the value proposition.  Like most things in the life science industry, this is simple but not easy. Clearly the current times have strained the schedules of…

Human capital is the most valuable resource for life science organizations. However, ever-changing workforce requirements can be challenging, which the pharma industry can overcome by outsourcing services.

Besides the pressure to maintain lower healthcare costs and increased competition from new entrants, life science companies find it challenging to market themselves and expand their reach.

Getting on the formulary is more difficult than ever before, given the number of new, high-cost drugs that are entering the market. That’s one of the reasons why Frank Dolan sat down with Steve O’Malley, Executive Vice President of Market Access at Two Labs, as part of the Life Science Leader Lab series.

The life sciences field is very complicated, but before you can get your product in the hands of patients who need them, you first need to get approved by payers.

The traditional methods of generating revenue in pharmaceutical markets are no longer effective. To deliver positive results for their businesses, the healthcare industry must consider patient loyalty as part of their marketing strategy.

Here are eight strategies to boost virtual sales in the healthcare industry during these unprecedented times:

Catching up with Tamar Frank Dolan, CEO of ARSENAL ADVISORS, caught up with Tamar Thompson, Vice President of Government Affairs at Alexion Pharmaceuticals, at the REIMAGINE BioPharma Summit on February 25, 2021 With so much activity and uncertainty in Washington, Tamar shared her outlook on the issues that the biotech, pharmaceutical, and medtech industries should…

Mastering the Art of Virtual Sales Calls for BioPharma & MedTech The Covid-19 pandemic has changed how we live, and especially how we work. With a majority of the workforce around the world going remote, the pandemic has revealed the cracks in the processes workers and corporations have been using for so many years.  It…

4 Myths About the Biopharma Industry Many myths and conspiracy theories surround the pharma sector, from exaggerating production costs to giving the public sector credit for developing medicines. The pharmaceutical market in the U.S. grew at a rate of 4% in 2019, and it’ll be worth $685.45 billion by 2023. With such vast potential in…

Life science conferences and summits provide a unique platform to share ideas and emerging knowledge with the larger medical research community. Most biotech and pharma industry stakeholders share similar goals: reduce the rate of infectious diseases, save patients from life-threatening conditions, find tailored treatments to minimize health risks, combat severe illnesses, and develop tools for…